Selective inhibitors of adenosine monophosphate deaminase for the treatment of optic nerve and retinal damage
US6300328A · kind A · utility
26Cited by
5References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 28, 2000 |
| Grant date | Oct 9, 2001 |
| Priority date | — |
| Expiry date | Jul 28, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/551
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Selective AMPDA inhibitors for preventing and treating damage to the optic nerve and/or retina are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.